ISV403

· Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISV403, covering 2009-08-13 to 2009-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis [Phase 2]